Skip to main navigation
logo
Logo

Site - Top Nav

  • About Iveric
  • Our Commitment
  • Why Iveric?
  • Clinical Programs
  • Investor Relations
  • Contact Us

Site - IR Nav

  • Investor Relations
  • News
  • Events & Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • IRS Form 8937
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor FAQs
  • Derivative Settlement
  • Contact Us

Press Releases

03.02.2023
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03.01.2023
Iveric Bio Reports Fourth Quarter and Full Year 2022 Operational Highlights and Financial Results
03.01.2023
Iveric Bio Announces Vision Loss Reduction Data in Geographic Atrophy from Avacincaptad Pegol GATHER Trials
02.28.2023
Iveric Bio to Present at the Cowen 43rd Annual Health Care Conference
02.22.2023
Iveric Bio to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on Wednesday, March 1, 2023
02.16.2023
Iveric Bio Announces FDA Accepts New Drug Application and Grants Priority Review for Avacincaptad Pegol for the Treatment of Geographic Atrophy
02.02.2023
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01.04.2023
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01.03.2023
Iveric Bio Announces the Addition of Pravin U. Dugel, MD, to its Board of Directors
12.20.2022
Iveric Bio Announces Completion of Rolling NDA Submission to FDA for Avacincaptad Pegol for the Treatment of Geographic Atrophy

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

Site - Shareholder Tools

Printed Materials
Printed Materials
Email Alerts
Email Alerts
Downloads
Downloads
RSS Feeds
RSS Feeds
Print
Print
Share This
Share This
Twitter
Twitter

Site - Footer Nav

  • Contact Us
  • Careers
  • Expanded Access
  • Privacy Policy
  • Sitemap